Cargando…
Mesenchymal stem cells confer chemoresistance in breast cancer via a CD9 dependent mechanism
The development of chemotherapy drug resistance remains a significant barrier for effective therapy in several cancers including breast cancer. Bone marrow-derived mesenchymal stem cells (BMMSCs) have previously been shown to influence tumor progression and the development of chemoresistance. In the...
Autores principales: | Ullah, Mujib, Akbar, Asma, Ng, Nathan Norton, Concepcion, Waldo, Thakor, Avnesh S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6544397/ https://www.ncbi.nlm.nih.gov/pubmed/31191817 http://dx.doi.org/10.18632/oncotarget.26952 |
Ejemplares similares
-
An emerging role of CD9 in stemness and chemoresistance
por: Ullah, Mujib, et al.
Publicado: (2019) -
Stem cell-derived extracellular vesicles: role in oncogenic processes, bioengineering potential, and technical challenges
por: Ullah, Mujib, et al.
Publicado: (2019) -
The role of ultrasound in enhancing mesenchymal stromal cell‐based therapies
por: Liu, Daniel D., et al.
Publicado: (2020) -
Pulsed focused ultrasound enhances the therapeutic effect of mesenchymal stromal cell-derived extracellular vesicles in acute kidney injury
por: Ullah, Mujib, et al.
Publicado: (2020) -
HSP70-Mediated NLRP3 Inflammasome Suppression Underlies Reversal of Acute Kidney Injury Following Extracellular Vesicle and Focused Ultrasound Combination Therapy
por: Ullah, Mujib, et al.
Publicado: (2020)